Clinical overlap between fibromyalgia and myalgic encephalomyelitis. A systematic review and meta-analysis

• Published in: Autoimmunity reviews Vol. 21; no. 8; p. 103129
• Main Authors: Ramírez-Morales, Ricardo, Bermúdez-Benítez, Elyzabeth, Martínez-Martínez, Laura-Aline, Martínez-Lavín, Manuel
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.08.2022
• Subjects: Dorsal root ganglia; Fatigue Syndrome, Chronic - complications; Fatigue Syndrome, Chronic - diagnosis; Fatigue Syndrome, Chronic - epidemiology; Fibromyalgia; Fibromyalgia - complications; Fibromyalgia - diagnosis; Fibromyalgia - epidemiology; Humans; meta-analysis; Myalgic encephalomyelitis; Systematic review; Fibromyalgia; meta-analysis; Systematic review; Dorsal root ganglia; Myalgic encephalomyelitis
• ISSN: 1568-9972; 1568-9972; 1873-0183
• DOI: 10.1016/j.autrev.2022.103129

Myalgic encephalomyelitis is an illness characterized by profound malaise after mental or physical effort occurring in patients already suffering from constant fatigue. On the other hand, widespread pain and widespread allodynia are the core fibromyalgia clinical features. There is controversy on these two syndromes alikeness. Through the years, different diagnostic and/or classification criteria have been put forward to appraise both fibromyalgia and myalgic encephalomyelitis. The epidemiology of these two illnesses, and their overlap, may vary accordingly to the used definition. The most recent Wolfe et al. 2016 fibromyalgia diagnostic criteria incorporates three myalgic encephalomyelitis features including fatigue, waking unrefreshed and dyscognition. The objective of this meta-analysis was to define the clinical overlap between fibromyalgia and myalgic encephalomyelitis based on a systematic literature review. PubMed, Embase, Lilacs, and Cochrane data bases were searched on January 25, 2021 linking the medical subject heading “Fibromyalgia” to the following terms “chronic fatigue syndrome”, “myalgic encephalomyelitis” and “systemic exertion intolerance disease”. Our review included all original articles in which the clinical overlap between fibromyalgia and myalgic encephalomyelitis could be quantified based on recognized diagnostic or classification criteria. Articles scrutiny and selection followed the PRISMA guidelines. Each study quality was assessed according to GRADE recommendations. The global clinical overlap was calculated using a fixed effect model with inverse variance-weighted average method. Twenty one publications were included in the meta-analysis. Reviewed studies were highly dissimilar in their design, objectives, sample size, diagnostic criteria, and/or outcomes yielding a 98% heterogeneity index. Nevertheless, the clinical overlap between fibromyalgia and myalgic encephalomyelitis was a well defined outcome that could be reliably calculated despite the high heterogeneity value. All reviewed publications had moderate GRADE evidence level. Most evaluated articles used the old 1990 Wolfe et al. fibromyalgia diagnostic criteria. Myalgic encephalomyelitis and fibromyalgia diagnoses overlapped in 47.3% (95% CI: 45.97–48.63) of the reported cases. This meta-analysis found prominent clinical overlap between fibromyalgia and myalgic encephalomyelitis. It seems likely that this concordance would be even higher when using the most recent Wolfe et al. 2016 fibromyalgia diagnostic criteria. •There is controversy on fibromyalgia – myalgic encephalomyelitis clinical overlap.•This systematic review with meta-analysis explores this issue.•Myalgic encephalomyelitis and fibromyalgia diagnoses overlapped in 47.3% (95% CI: 45.97–48.63) of the reported cases.•This high clinical concordance likely reflects shared pathogenic mechanisms.